6ZP
2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile
Created: | 2016-08-01 |
Last modified: | 2016-10-19 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 42 |
Chiral Atom Count | 0 |
Bond Count | 45 |
Aromatic Bond Count | 18 |
Chemical Component Summary | |
---|---|
Name | 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile |
Systematic Name (OpenEye OEToolkits) | 2-(2-oxidanylidene-1-phenyl-5-pyridin-2-yl-pyridin-3-yl)benzenecarbonitrile |
Formula | C23 H15 N3 O |
Molecular Weight | 349.385 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 12.01 | N#Cc1ccccc1C3=CC(c2ncccc2)=CN(C3=O)c4ccccc4 |
SMILES | CACTVS | 3.385 | O=C1N(C=C(C=C1c2ccccc2C#N)c3ccccn3)c4ccccc4 |
SMILES | OpenEye OEToolkits | 2.0.5 | c1ccc(cc1)N2C=C(C=C(C2=O)c3ccccc3C#N)c4ccccn4 |
Canonical SMILES | CACTVS | 3.385 | O=C1N(C=C(C=C1c2ccccc2C#N)c3ccccn3)c4ccccc4 |
Canonical SMILES | OpenEye OEToolkits | 2.0.5 | c1ccc(cc1)N2C=C(C=C(C2=O)c3ccccc3C#N)c4ccccn4 |
InChI | InChI | 1.03 | InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H |
InChIKey | InChI | 1.03 | PRMWGUBFXWROHD-UHFFFAOYSA-N |
Drug Info: DrugBank
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
DrugBank ID | DB08883 |
---|---|
Name | Perampanel |
Groups | approved |
Description | Perampanel is a noncompetitive AMPA glutamate receptor antagonist. It is marketed under the name Fycompa™ and is indicated as an adjunct in patients over 12 years old for the treatment of partial-onset seizures that may or may not occur with generalized seizures. The FDA label includes an important black-boxed warning of serious or life-threatening behavioral and psychiatric reactions in patients taking Fycompa™. |
Synonyms |
|
Brand Names |
|
Indication | Perampanel is indicated for the treatment of partial-onset seizures with or without secondarily generalized seizures in epileptic patients four years of age and older. It is also indicated as an adjunct in the treatment of primary generalized tonic-clonic seizures in epileptic patients aged 12 years and older.[L40913] |
Categories |
|
ATC-Code | N03AX22 |
CAS number | 380917-97-5 |
Drug Targets
DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Glutamate receptor 2 | MQKIMHISVLLSPVLWGLIFGVSSNSIQIGGLFPRGADQEYSAFRVGMVQ... | unknown | inhibitor |
Glutamate receptor 3 | MARQKKMGQSVLRAVFFLVLGLLGHSHGGFPNTISIGGLFMRNTVQEHSA... | unknown | inhibitor |
Glutamate receptor 4 | MRIISRQIVLLFSGFWGLAMGAFPSSVQIGGLFIRNTDQEYTAFRLAIFL... | unknown | inhibitor |
Glutamate receptor 1 | MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLT... | unknown | antagonist |
Cytochrome P450 3A4 | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI... | unknown | substrate,inducer |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1214124 |
PubChem | 9924495 |
ChEMBL | CHEMBL1214124 |
ChEBI | CHEBI:71013 |